Aurobindo Pharma Announcements
Aurobindo Pharma Limited has informed the Exchange about General Updates
12 Mar, 2026 | 11:01am • Source: NSE
Intimation of classification of Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the Company as VAI by the US FDA.
12 Mar, 2026 | 09:44am • Source: BSE
Intimation of plant visit by a group of investors on 17.03.2026.
11 Mar, 2026 | 01:14pm • Source: BSE
Intimation of plant visit by investor group on 16.03.2026.
11 Mar, 2026 | 01:11pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
09 Mar, 2026 | 02:55pm • Source: NSE
Intimation of investor meet to be held on 13.03.2026.
09 Mar, 2026 | 02:40pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Eugia Pharma announces launch of Pomalidomide Capsules in the...
04 Mar, 2026 | 03:49pm • Source: NSE
Submission of press release on launch of Pomalidomide Capsules 1 mg, 2 mg, 3 mg and 4 mg in the US market by Eugia Pharma...
04 Mar, 2026 | 12:08pm • Source: BSE
Intimation of investor meet.
02 Mar, 2026 | 12:19pm • Source: BSE
Submission of press release that Eugia Pharma received USFDA approval for Everolimus Tablets
26 Feb, 2026 | 11:51am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
25 Feb, 2026 | 12:10pm • Source: NSE
Submission of Notice published in news papers for attention of shareholders about postal ballot notice and remote e-voting
25 Feb, 2026 | 11:59am • Source: BSE
Intimation of incorporation of a wholly owned subsidiary company in India
24 Feb, 2026 | 04:33pm • Source: BSE
Submission of Postal Ballot Notice dated February 9, 2026 seeking approval of the shareholders by way of special resolution for appointment of Dr. Punita Kumar...
24 Feb, 2026 | 02:54pm • Source: BSE
Submission of Clarification on News item in www.ndtvprofit.com
18 Feb, 2026 | 01:38pm • Source: BSE
The Exchange has sought clarification from Aurobindo Pharma Ltd on February 18, 2026, with reference to news appeared in https://www.ndtvprofit.com/ dated February 18, 2026 quoting...
18 Feb, 2026 | 11:53am • Source: BSE
Submission of transcript of earning call held on February 10, 2026 for Q3 FY2025-26 financial results.
16 Feb, 2026 | 11:17am • Source: BSE
Submission of the copies of notice published by the Company on February 13, 2026 in Business Standard and Nava Telangana regarding special window for re-lodgement...
13 Feb, 2026 | 11:43am • Source: BSE
Submission of copies of newspaper advertisement of the financial results of the Company for the third quarter and nine months period ended December 31, 2025...
11 Feb, 2026 | 11:51am • Source: BSE